Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Inozyme Pharma, Inc. (INZY) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Inozyme Pharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1693011.
Total stock buying since 2020: $104,101,317.
Total stock sales since 2020: $7,927,209.
Total stock option exercises since 2020: $154,085.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 0 | $0 | 157,230 | $154,085 |
| 2024 | 0 | $0 | 7,523 | $52,209 | 25,000 | $0 |
| 2023 | 2,667,030 | $13,254,772 | 0 | $0 | 0 | $0 |
| 2022 | 3,616,950 | $13,346,545 | 0 | $0 | 0 | $0 |
| 2021 | 0 | $0 | 375,000 | $7,875,000 | 0 | $0 |
| 2020 | 4,843,750 | $77,500,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-05 | 0 | $0 | 0 | $0 | 157,230 | $154,085 |
| 2024-04 | 0 | $0 | 7,523 | $52,209 | 25,000 | $0 |
| 2023-08 | 1,666,666 | $7,999,996 | 0 | $0 | 0 | $0 |
| 2023-05 | 447,932 | $2,849,997 | 0 | $0 | 0 | $0 |
| 2023-03 | 552,432 | $2,404,779 | 0 | $0 | 0 | $0 |
| 2022-04 | 3,616,950 | $13,346,545 | 0 | $0 | 0 | $0 |
| 2021-01 | 0 | $0 | 375,000 | $7,875,000 | 0 | $0 |
| 2020-07 | 4,843,750 | $77,500,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-15 | Bolte Axel | Option Ex | 157,230 | .98 | 154,085 |
| 2024-04-02 | Treco Douglas A (CEO) | Sale | 7,523 | 6.94 | 52,209 |
| 2024-04-01 | Treco Douglas A (CEO) | Option Ex | 25,000 | .00 | 0 |
| 2023-08-01 | Pivotal Bioventure Partners Fund I U.g.p. Ltd | Buy | 833,333 | 4.80 | 3,999,998 |
| 2023-08-01 | Hopfner Robert Lorne | Buy | 833,333 | 4.80 | 3,999,998 |
| 2023-05-12 | Hopfner Robert Lorne (Director) | Buy | 228,702 | 6.25 | 1,429,387 |
| 2023-05-11 | Hopfner Robert Lorne (Director) | Buy | 219,230 | 6.48 | 1,420,610 |
| 2023-03-29 | Hopfner Robert Lorne (Director) | Buy | 344,592 | 4.54 | 1,563,758 |
| 2023-03-28 | Hopfner Robert Lorne (Director) | Buy | 156,766 | 4.16 | 652,303 |
| 2023-03-27 | Hopfner Robert Lorne (Director) | Buy | 51,074 | 3.69 | 188,718 |
| 2022-04-19 | Subramanian Sanjay (SVP, CFO) | Buy | 27,100 | 3.69 | 99,999 |
| 2022-04-19 | Pivotal Bioventure Partners Fund I U.g.p., Ltd (Director) | Buy | 1,070,000 | 3.69 | 3,948,300 |
| 2022-04-19 | Bjarke Henric Bjorn (SVP, COO) | Buy | 27,100 | 3.69 | 99,999 |
| 2022-04-19 | Bolte Axel (Chief Executive Officer) | Buy | 67,750 | 3.69 | 249,997 |
| 2022-04-19 | Hopfner Robert Lorne (Director) | Buy | 1,070,000 | 3.69 | 3,948,300 |
| 2022-04-19 | Enright Patrick G (10% Owner) | Buy | 1,355,000 | 3.69 | 4,999,950 |
| 2021-01-28 | Novo Holdings A/s (10% Owner) | Sale | 375,000 | 21.00 | 7,875,000 |
| 2020-07-28 | Pivotal Bioventure Partners Fund I U.g.p., Ltd (10% Owner) | Buy | 187,500 | 16.00 | 3,000,000 |
| 2020-07-28 | Rock Springs Capital Llc (10% Owner) | Buy | 600,000 | 16.00 | 9,600,000 |
| 2020-07-28 | Nea 15 Gp, Llc (10% Owner) | Buy | 250,000 | 16.00 | 4,000,000 |
| 2020-07-28 | Makhzoumi Mohamad (10% Owner) | Buy | 250,000 | 16.00 | 4,000,000 |
| 2020-07-28 | Shah Rajeev M. | Buy | 600,000 | 16.00 | 9,600,000 |
| 2020-07-28 | Florence Anthony A. Jr. (10% Owner) | Buy | 250,000 | 16.00 | 4,000,000 |
| 2020-07-28 | Sonsini Peter W. (10% Owner) | Buy | 250,000 | 16.00 | 4,000,000 |
| 2020-07-28 | Hopfner Robert Lorne (Director) | Buy | 187,500 | 16.00 | 3,000,000 |
| 2020-07-28 | Novo Holdings A/s (10% Owner) | Buy | 375,000 | 16.00 | 6,000,000 |
| 2020-07-28 | Baskett Forest (10% Owner) | Buy | 250,000 | 16.00 | 4,000,000 |
| 2020-07-28 | Enright Patrick G (10% Owner) | Buy | 625,000 | 16.00 | 10,000,000 |
| 2020-07-28 | Sandell Scott D (10% Owner) | Buy | 250,000 | 16.00 | 4,000,000 |
| 2020-07-28 | Makower Joshua (10% Owner) | Buy | 250,000 | 16.00 | 4,000,000 |
| 2020-07-28 | Powell Michael (10% Owner) | Buy | 437,500 | 16.00 | 7,000,000 |
| 2020-07-28 | Sanofi (10% Owner) | Buy | 81,250 | 16.00 | 1,300,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of INZY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Inozyme Pharma, Inc. (symbol INZY, CIK number 1693011) see the Securities and Exchange Commission (SEC) website.